Elderly patients denied best treatment for fear of side effects

This release is also available in French, Italian, and German.

Most elderly women with advanced ovarian cancer are not given optimal treatment for fear of an adverse reaction, although there is little evidence to show that they are at greater risk than younger patients, say oncologists in France. The results of an investigation involving 83 women over the age of 70 were announced today (20 October 2002) and will help oncologists identify which patients are most like to benefit from standard chemotherapy.

Speaking at the European Society for Medical Oncology Congress in Nice, France, Dr Gilles Freyer from Centre Hospitalier Lyon Sud, France, said, "We simply do not know if elderly patients can tolerate these powerful drugs, because clinical trials often exclude patients over the age of 70 years, so the results that emerge are not fully representative of the age range of patients we have to treat."

There are a number of factors that have to be taken into account when planning a treatment strategy for older people. They may be more vulnerable to the toxic side effects of the therapy. They experience more psychological problems, such as depression, and it can be difficult for an oncologist to communicate effectively with an elderly person if their cognition is impaired. Transport to and from hospital is one of the practical difficulties for older people.

Patients who are depressed before treatment begins, patients who lack autonomy and those living in institution are at risk of toxicity and the treatment may be less effective. "Perhaps this is because they are more fragile and need more care than elderly women who lead independent lives," Dr Freyer suggested. Medication being taken at the same time for other

Contact: Gracemarie Bricalli
European Society for Medical Oncology

Page: 1 2

Related biology news :

1. Striking A Healthy Balance For The Elderly
2. Dietary Determinants Of Iron Stores In A Free-Living Elderly Population: The Framingham Heart Study
3. Study Reviews Medication Use In Elderly Cardiac Patients After Discharge
4. Trial shows which brain cancer patients benefit from temozolomide
5. Study of flu patients reveals virus outsmarting key drug
6. Decreasing toxins in brains of Alzheimers patients keep cognitive deficits at bay
7. Activated signaling pathway may predict lung cancer patients response to gefitinib
8. Targeted therapy for lung cancer patients shows promise in extending lives
9. Breast cancer patients failed by treatment with taxol and taxotere respond to abraxane
10. Study finds that only half of a commonly used cancer drug is activated in cancer patients
11. APP reports Abraxane(TM) is active in breast cancer patients who failed taxol or taxotere

Post Your Comments:

(Date:1/14/2019)... ... January 14, 2019 , ... CellMax Life , a ... blood, will present new findings at the ASCO Gastrointestinal Cancer Symposium in San ... results from this study show CellMax Life’s blood test, based on its proprietary ...
(Date:1/10/2019)... ... 2019 , ... Dr. Beanlands is the Vered Chair and Division Head of ... is also Director of its National Cardiac PET Centre, and Professor in the University's ... in the Department of Cellular and Molecular medicine. , He is a founding member ...
(Date:1/10/2019)... ... January 10, 2019 , ... A major goal for ... vitro studies and significantly more expensive in vivo studies in order to reduce ... address this need, researchers have begun to adopt 3D cell culture models which ...
Breaking Biology News(10 mins):
(Date:1/30/2019)... ... January 29, 2019 , ... Actus Therapeutics, a ... of the first patient in a phase 1/2 clinical study of ACTUS-101 in ... high morbidity and often leads to premature death. There are variable rates ...
(Date:1/30/2019)... VERONA, Italy (PRWEB) , ... January 30, 2019 ... ... Without Walls section of the international tasting 5StarWines to promote and give recognition ... sulfite wines. The Wine Without Walls selection takes place in Verona, Italy, contemporaneously ...
(Date:1/24/2019)... ... January 23, 2019 , ... ... has awarded microbiome research support in study design, planning, sample collection, and analysis ... Sciences, St. Augustine Campus in Trinidad led by Dr. Elaine Monica Davis, MBBS, ...
(Date:1/20/2019)... ... January 17, 2019 , ... Today, Advanced Solutions, ... of a specialized automation technology, titled Automate 3D. Automate 3D, produced by Advanced ... and drawings to deliver to end-users, customers, and ERP systems. , ...
Breaking Biology Technology:
Cached News: